Healthcare Icon
Number 1 Wellbeing & Healthcare Platform
Extra Twenty Icon
Get 40% off on 1st online pharmacy purchase Use Code: NEW40
IC Cart
shareIcon
Thumbnail ImageThumbnail ImageThumbnail ImageThumbnail Image

Indicardin 40mg 50 Tablet

SAR  15.00
Only 4 left, order now
Indicardin 40mg 50 Tablet
90 mins delivery
Free Shipping

Trusted & Free Shipping

100% Secure Payment

100% Secure Payment

Genuine Brands

Genuine Brands

Overview

  • Mechanism of Action: Beta-1 adrenergic receptor blocker
  • Therapeutic Indications: Hypertension, angina pectoris, heart failure
  • Clinical Benefits: Reduced blood pressure, improved exercise tolerance, symptom management in heart failure
  • Additional Information: Follow prescribed dosage for optimal therapeutic effects

Benefits

  • Reduces blood pressure
  • Improves exercise tolerance in angina patients
  • Manages symptoms of heart failure
  • Effective in hypertension management

How to Use

  • Take as prescribed by doctor
  • Follow recommended dosage instructions
  • May be taken with or without food
  • Avoid abrupt discontinuation

Description

Indicardin 40mg is a medication classified as a beta-blocker, specifically targeting the beta-1 adrenergic receptors in the heart. Its mechanism of action involves blocking the effects of adrenaline, leading to decreased heart rate and blood pressure. Indicardin 40mg is indicated for the management of hypertension, angina pectoris, and heart failure. Clinical studies have shown that Indicardin 40mg effectively reduces blood pressure, improves exercise tolerance in angina patients, and helps in the management of heart failure symptoms. It is important to follow the prescribed dosage and recommendations from healthcare providers to achieve optimal therapeutic outcomes.

Specifications

Brand
Indicardin
Aster Product Type
NONRX
form
Tablet
gender
Unisex
life-stage
Adult
manufacturer
APM
material
Synthetic
Usage
Oral
quantity-per-pack
1
storage-temperature
Room Temperature
Pack Specification
Single
age-group
18+
Conditions
New
Legal Disclaimer